Angelo Argento
Internal Medicine · Broken Arrow, OKNPI 1467408831
Payments from drug & device makers
Across 80 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$299
- AstraZeneca$218
- Sunovion Pharmaceuticals Inc.$99
- Bayer$99
- Johnson & Johnson$97
- Takeda Pharmaceuticals U.S.A., Inc.$90
- plus $516 from 19 others
What the payments were for
- Food & beverage$1,418100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 18 | $299 |
| AstraZeneca | 8 | $218 |
| Sunovion Pharmaceuticals Inc. | 11 | $99 |
| Bayer | 6 | $99 |
| Johnson & Johnson | 1 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| Philips North America LLC | 4 | $59 |
| Merck | 4 | $50 |
| Insulet Corporation | 3 | $43 |
| Grifols USA, LLC | 2 | $42 |
| Mylan Specialty L.p. | 3 | $41 |
| Pfizer | 2 | $29 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Biomerieux Inc | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $24 |
| Harmony Biosciences LLC | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Medtronic | 1 | $17 |
| Amgen | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Abbott | 1 | $14 |
| Insmed, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$115
How this compares
$1,418 in reported general payments places this provider in the 70th percentile of 840 internal medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 102 | $117,394 |
| JardianceEmpagliflozin | 94 | $115,574 |
| EliquisApixaban | 91 | $104,318 |
| JanuviaSitagliptin Phosphate | 83 | $103,689 |
| MounjaroTirzepatide | 61 | $64,925 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $42,111 |
| UbrelvyUbrogepant | 17 | $25,499 |
| SymbicortBudesonide/Formoterol Fumarate | 50 | $19,538 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $17,287 |
| TrulicityDulaglutide | 14 | $15,051 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $13,522 |
| MyrbetriqMirabegron | 14 | $11,628 |
| Bydureon BciseExenatide Microspheres | 13 | $10,390 |
| LinzessLinaclotide | 16 | $10,211 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 394 | $9,533 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $14 | $122,530108 claims |
| Novo NordiskOzempic | $20 | $117,394102 claims |
| PfizerEliquis, Premarin | $29 | $112,001107 claims |
| MerckJanuvia | $50 | $103,68983 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $299 | $63,06358 claims |
| AstraZenecaSymbicort | $218 | $19,53850 claims |
| Sanofi-aventis U.S. LLCLantus | $26 | $6,19415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 840 internal medicine providers in Oklahoma.
Other internal medicine in Broken Arrow
- Ranilo VasquezBroken Arrow$15K
- Riley HillBroken Arrow$14K
- Rim TabbaaBroken Arrow$12K
- Al-Ola AbdallahTulsa$10.1M
- Melita TateTulsa$9.1M
- Sagila GeorgeOklahoma City$1.8M
- Ryan MorganOklahoma City$775K
- Renae MayerTulsa$766K
- George FreemanIdabel$742K
- Elise WiesnerNorman$584K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.